Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$200.41M-1.3%$194.01M-4.4%$194.79M-1.9%$196.03M+0.4%$203.07M+1.2%
$21M+57.3%$20.16M+50.8%$17.46M+43.2%$13.42M+14.8%$13.35M+12.5%
$179.41M-5.4%$173.85M-8.3%$177.32M-4.9%$182.61M-0.5%$189.72M+0.5%
89.5%-3.9pp89.6%-3.8pp91%-2.8pp93.2%-0.9pp93.4%-0.7pp
$26.71M-10.8%$30.18M-3.1%$28.94M-8.8%$31.01M+2.9%$29.93M-3.0%
$81.99M-3.4%$81.05M-4.1%$78.62M-16.2%$83.53M-7.0%$84.87M-9.2%
$24.81M-12.6%$26.82M-9.5%$23.94M+1.7%$32.01M+25.0%$28.38M+2.9%
$176.78M+0.3%$180M+0.2%$172.1M-4.6%$181.41M+3.8%$176.26M-2.5%
$23.63M-11.9%$14.01M-40.1%$22.68M+24.8%$14.62M-28.4%$26.81M+34.9%
11.8%-1.4pp7.2%-4.3pp11.6%+2.5pp7.5%-3.0pp13.2%+3.3pp
$9.81M-8.6%$9.77M-8.2%$10.4M-8.4%$10.83M-12.4%$10.73M-26.3%
-$8.17M-12.9%-$8.37M-24.7%-$8.49M-25.4%-$8.52M+30.7%-$7.23M+12.1%
$15.47M-21.0%$5.64M-66.2%$14.19M+24.4%$6.1M-24.8%$19.58M+68.1%
$6.93M+2.9%$4.47M-20.4%$8.77M+87.8%$4.98M+20.1%$6.73M+36.0%
$8.54M-33.5%$1.17M-89.4%$5.43M-19.5%$1.12M-71.8%$12.84M+91.9%
4.3%-2.1pp0.6%-4.8pp2.8%-0.6pp0.6%-1.5pp6.3%+3.0pp
$0.02-50.0%$0.00-100%$0.020.0%$0.00-100%$0.04+100%
$45.9M-1.4%$35.8M-19.2%$45.83M+22.9%$36.05M-5.0%$46.54M+26.3%
22.9%0.0pp18.5%-3.4pp23.5%+4.8pp18.4%-1.0pp22.9%+4.6pp
$23.63M-11.9%$14.01M-40.1%$22.68M+24.8%$14.62M-28.4%$26.81M+34.9%

FAQ

What is GoodRx Holdings, Inc.'s revenue?
GoodRx Holdings, Inc. (GDRX) generated $785.2M in revenue over the trailing twelve months, down 1.8% year over year.
Is GoodRx Holdings, Inc. profitable?
GoodRx Holdings, Inc. reported $16.2M in net income over the trailing twelve months, a 2.1% net margin.
What are GoodRx Holdings, Inc.'s profit margins?
Gross margin is 90.8% and operating margin is 9.5%, with a 2.1% net margin.
What is GoodRx Holdings, Inc.'s earnings per share?
GoodRx Holdings, Inc.'s diluted EPS over the trailing twelve months is $0.04.
Where does GoodRx Holdings, Inc.'s income statement data come from?
Every line is extracted from GoodRx Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.